Lastest Insider Transactions Of GILEAD SCIENCES, INC. ( GILD ) |
Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
GILD | GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | 2024-11-29 | Sell | 248,645 | 92.76 | 23,065,270 | 2024-12-03 14:43:20 |
GILD | GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | 2024-11-29 | Option Exercise | 248,645 | 70.50 | 17,528,576 | 2024-12-03 14:43:20 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2024-11-27 | Sell | 164,211 | 91.92 | 15,094,013 | 2024-11-29 20:10:23 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2024-11-27 | Option Exercise | 145,413 | 62.44 | 9,079,689 | 2024-11-29 20:10:23 |
GILD | GILEAD SCIENCES, INC. | Bluestone Jeffrey | Directior | 2024-11-26 | Sell | 6,788 | 91.39 | 620,356 | 2024-11-27 18:14:41 |
GILD | GILEAD SCIENCES, INC. | Bluestone Jeffrey | Directior | 2024-11-26 | Option Exercise | 10,000 | 61.24 | 612,442 | 2024-11-27 18:14:41 |
GILD | GILEAD SCIENCES, INC. | Mercier Johanna | Chief Commercial Officer | 2024-11-06 | Sell | 5,000 | 91.28 | 456,400 | 2024-11-07 16:38:35 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2024-11-06 | Sell | 25,590 | 91.50 | 2,341,485 | 2024-11-07 16:32:29 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2024-11-06 | Option Exercise | 25,000 | 57.92 | 1,448,000 | 2024-11-07 16:32:29 |
GILD | GILEAD SCIENCES, INC. | Telman Deborah H | EVP, Corporate Affairs & GC | 2024-10-25 | Option Exercise | 514 | 0.00 | 0 | 2024-10-28 15:09:29 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2024-10-01 | Sell | 2,000 | 83.83 | 167,660 | 2024-10-02 16:58:23 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2024-09-12 | Sell | 21,246 | 84.50 | 1,795,287 | 2024-09-13 19:07:56 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2024-09-12 | Option Exercise | 25,000 | 57.92 | 1,448,000 | 2024-09-13 19:07:56 |
GILD | GILEAD SCIENCES, INC. | Mercier Johanna | Chief Commercial Officer | 2024-09-12 | Sell | 29,357 | 83.78 | 2,459,577 | 2024-09-13 17:08:41 |
GILD | GILEAD SCIENCES, INC. | Mercier Johanna | Chief Commercial Officer | 2024-08-13 | Sell | 5,490 | 73.98 | 406,150 | 2024-08-14 14:23:44 |
GILD | GILEAD SCIENCES, INC. | Patterson Sandra | SVP, Controllership | 2024-08-10 | Option Exercise | 3,678 | 0.00 | 0 | 2024-08-12 16:22:36 |
GILD | GILEAD SCIENCES, INC. | Telman Deborah H | EVP, Corporate Affairs & GC | 2024-07-25 | Option Exercise | 8,744 | 0.00 | 0 | 2024-07-26 17:28:51 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2024-07-01 | Sell | 2,000 | 68.63 | 137,260 | 2024-07-01 20:06:29 |
GILD | GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | 2024-06-10 | Option Exercise | 3,639 | 0.00 | 0 | 2024-06-11 19:25:27 |
GILD | GILEAD SCIENCES, INC. | Patterson Sandra | SVP, Controllership | 2024-06-10 | Option Exercise | 901 | 0.00 | 0 | 2024-06-11 19:23:09 |
GILD | GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO | 2024-06-10 | Option Exercise | 10,295 | 0.00 | 0 | 2024-06-11 19:20:42 |
GILD | GILEAD SCIENCES, INC. | Mercier Johanna | Chief Commercial Officer | 2024-06-10 | Option Exercise | 3,751 | 0.00 | 0 | 2024-06-11 19:18:31 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2024-06-10 | Option Exercise | 3,820 | 0.00 | 0 | 2024-06-11 19:15:14 |
GILD | GILEAD SCIENCES, INC. | Telman Deborah H | EVP, Corporate Affairs & GC | 2024-06-10 | Option Exercise | 638 | 0.00 | 0 | 2024-06-11 19:12:00 |
GILD | GILEAD SCIENCES, INC. | Telman Deborah H | EVP, Corporate Affairs & GC | 2024-04-25 | Option Exercise | 515 | 0.00 | 0 | 2024-04-26 16:30:43 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2024-04-01 | Sell | 2,000 | 72.96 | 145,920 | 2024-04-02 18:38:27 |
GILD | GILEAD SCIENCES, INC. | Telman Deborah H | EVP, Corporate Affairs & GC | 2024-03-10 | Option Exercise | 2,555 | 0.00 | 0 | 2024-03-12 16:19:08 |
GILD | GILEAD SCIENCES, INC. | Patterson Sandra | SVP, Controllership | 2024-03-10 | Option Exercise | 2,682 | 0.00 | 0 | 2024-03-12 15:57:35 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2024-03-10 | Option Exercise | 10,401 | 0.00 | 0 | 2024-03-11 21:14:09 |
GILD | GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO | 2024-03-10 | Option Exercise | 29,940 | 0.00 | 0 | 2024-03-11 21:11:24 |
GILD | GILEAD SCIENCES, INC. | Mercier Johanna | Chief Commercial Officer | 2024-03-10 | Option Exercise | 9,844 | 0.00 | 0 | 2024-03-11 21:03:04 |
GILD | GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | 2024-03-10 | Option Exercise | 9,732 | 0.00 | 0 | 2024-03-11 20:59:54 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2024-02-28 | Sell | 10,230 | 72.82 | 744,984 | 2024-02-29 18:35:55 |
GILD | GILEAD SCIENCES, INC. | Telman Deborah H | EVP, Corporate Affairs & GC | 2024-01-25 | Option Exercise | 514 | 0.00 | 0 | 2024-01-26 16:31:43 |
GILD | GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | 2024-01-16 | Sell | 5,000 | 85.78 | 428,900 | 2024-01-17 18:01:02 |
GILD | GILEAD SCIENCES, INC. | Mercier Johanna | Chief Commercial Officer | 2024-01-09 | Sell | 8,242 | 85.23 | 702,466 | 2024-01-10 15:58:36 |
GILD | GILEAD SCIENCES, INC. | Mercier Johanna | Chief Commercial Officer | 2023-12-10 | Option Exercise | 2,730 | 0.00 | 0 | 2023-12-11 19:15:11 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2023-12-10 | Option Exercise | 2,779 | 0.00 | 0 | 2023-12-11 19:10:54 |
GILD | GILEAD SCIENCES, INC. | Patterson Sandra | SVP, Controllership | 2023-12-10 | Option Exercise | 518 | 0.00 | 0 | 2023-12-11 19:08:00 |
GILD | GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO | 2023-12-10 | Option Exercise | 7,347 | 0.00 | 0 | 2023-12-11 19:04:37 |
GILD | GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | 2023-12-10 | Option Exercise | 2,617 | 0.00 | 0 | 2023-12-11 19:00:36 |
GILD | GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | 2023-11-10 | Option Exercise | 1,912 | 0.00 | 0 | 2023-11-13 18:21:32 |
GILD | GILEAD SCIENCES, INC. | Telman Deborah H | EVP, Corporate Affairs & GC | 2023-10-25 | Option Exercise | 514 | 0.00 | 0 | 2023-10-26 17:56:50 |
GILD | GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | 2023-10-17 | Sell | 5,000 | 80.00 | 400,017 | 2023-10-18 16:31:56 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2023-09-12 | Sell | 1,501 | 76.99 | 115,562 | 2023-09-13 18:50:26 |
GILD | GILEAD SCIENCES, INC. | Mercier Johanna | Chief Commercial Officer | 2023-09-10 | Option Exercise | 2,730 | 0.00 | 0 | 2023-09-11 20:44:10 |
GILD | GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | 2023-09-10 | Option Exercise | 2,619 | 0.00 | 0 | 2023-09-11 20:40:57 |
GILD | GILEAD SCIENCES, INC. | Patterson Sandra | SVP, Controllership | 2023-09-10 | Option Exercise | 519 | 0.00 | 0 | 2023-09-11 20:37:41 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2023-09-10 | Option Exercise | 2,779 | 0.00 | 0 | 2023-09-11 20:19:06 |
GILD | GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO | 2023-09-10 | Option Exercise | 7,348 | 0.00 | 0 | 2023-09-11 20:11:25 |
GILD | GILEAD SCIENCES, INC. | Patterson Sandra | SVP, Controllership | 2023-08-10 | Option Exercise | 4,484 | 0.00 | 0 | 2023-08-11 16:36:30 |
GILD | GILEAD SCIENCES, INC. | Telman Deborah H | EVP, Corporate Affairs & GC | 2023-07-25 | Option Exercise | 10,289 | 0.00 | 0 | 2023-07-26 16:53:55 |
GILD | GILEAD SCIENCES, INC. | Mercier Johanna | Chief Commercial Officer | 2023-07-24 | Option Exercise | 7,505 | 0.00 | 0 | 2023-07-25 18:15:31 |
GILD | GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | 2023-07-20 | Sell | 5,000 | 80.00 | 400,000 | 2023-07-21 17:30:39 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2023-06-13 | Sell | 1,485 | 76.90 | 114,197 | 2023-06-14 17:48:50 |
GILD | GILEAD SCIENCES, INC. | Patterson Sandra | SVP, Controllership | 2023-06-10 | Option Exercise | 517 | 0.00 | 0 | 2023-06-12 16:50:04 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2023-06-10 | Option Exercise | 2,779 | 0.00 | 0 | 2023-06-12 16:45:50 |
GILD | GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO | 2023-06-10 | Option Exercise | 7,346 | 0.00 | 0 | 2023-06-12 16:42:53 |
GILD | GILEAD SCIENCES, INC. | Mercier Johanna | Chief Commercial Officer | 2023-06-10 | Option Exercise | 2,730 | 0.00 | 0 | 2023-06-12 16:39:57 |
GILD | GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | 2023-06-10 | Option Exercise | 2,618 | 0.00 | 0 | 2023-06-12 16:37:10 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2023-03-13 | Sell | 6,126 | 78.99 | 483,893 | 2023-03-14 18:20:38 |
GILD | GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO | 2023-03-10 | Option Exercise | 30,288 | 0.00 | 0 | 2023-03-14 12:03:01 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2023-03-10 | Option Exercise | 11,454 | 0.00 | 0 | 2023-03-13 21:09:50 |
GILD | GILEAD SCIENCES, INC. | Patterson Sandra | SVP, Controllership | 2023-03-10 | Option Exercise | 2,921 | 0.00 | 0 | 2023-03-13 21:04:37 |
GILD | GILEAD SCIENCES, INC. | Mercier Johanna | Chief Commercial Officer | 2023-03-10 | Option Exercise | 10,976 | 0.00 | 0 | 2023-03-13 21:00:54 |
GILD | GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | 2023-03-10 | Option Exercise | 10,419 | 0.00 | 0 | 2023-03-13 20:55:59 |
GILD | GILEAD SCIENCES, INC. | Lofton Kevin E | Directior | 2023-03-09 | Option Exercise | 8,442 | 52.38 | 442,192 | 2023-03-10 17:23:32 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2023-03-01 | Sell | 12,984 | 79.96 | 1,038,225 | 2023-03-02 19:01:10 |
GILD | GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO | 2023-03-01 | Option Exercise | 11,362 | 0.00 | 0 | 2023-03-02 18:48:31 |
GILD | GILEAD SCIENCES, INC. | Wilfong Diane E. | SVP, Controller & CAO | 2023-02-06 | Option Exercise | 1,864 | 0.00 | 0 | 2023-02-07 17:47:01 |
GILD | GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | 2023-02-06 | Option Exercise | 1,817 | 0.00 | 0 | 2023-02-07 15:50:08 |
GILD | GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | 2023-02-06 | Option Exercise | 1,817 | 0.00 | 0 | 2023-02-07 15:50:08 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2022-12-30 | Sell | 553 | 85.33 | 47,187 | 2023-01-03 20:05:19 |
GILD | GILEAD SCIENCES, INC. | Wilfong Diane E. | SVP, Controller & CAO | 2022-12-10 | Option Exercise | 318 | 0.00 | 0 | 2022-12-13 15:15:22 |
GILD | GILEAD SCIENCES, INC. | Parsey Merdad | Chief Medical Officer | 2022-12-10 | Option Exercise | 1,039 | 0.00 | 0 | 2022-12-13 15:14:10 |
GILD | GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO | 2022-12-10 | Option Exercise | 3,300 | 0.00 | 0 | 2022-12-13 15:13:24 |
GILD | GILEAD SCIENCES, INC. | Mercier Johanna | Chief Commercial Officer | 2022-12-10 | Option Exercise | 990 | 0.00 | 0 | 2022-12-13 15:12:10 |
GILD | GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | 2022-12-10 | Option Exercise | 1,027 | 0.00 | 0 | 2022-12-13 15:11:17 |